129 related articles for article (PubMed ID: 11315626)
1. Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications.
Baithun SI; Naase M; Blanes A; Diaz-Cano SJ
Virchows Arch; 2001 Mar; 438(3):289-97. PubMed ID: 11315626
[TBL] [Abstract][Full Text] [Related]
2. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
3. Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder.
Diaz-Cano SJ; Blanes A; Rubio J; Matilla A; Wolfe HJ
Lab Invest; 2000 Mar; 80(3):279-89. PubMed ID: 10744064
[TBL] [Abstract][Full Text] [Related]
4. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
[TBL] [Abstract][Full Text] [Related]
5. Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder: role of TP53 and NF1 genes.
Blanes A; Rubio J; Martinez A; Wolfe HJ; Diaz-Cano SJ
Am J Clin Pathol; 2002 Jul; 118(1):93-100. PubMed ID: 12109862
[TBL] [Abstract][Full Text] [Related]
6. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
[TBL] [Abstract][Full Text] [Related]
7. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
[TBL] [Abstract][Full Text] [Related]
8. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
[TBL] [Abstract][Full Text] [Related]
9. Current understanding of the biology of advanced bladder cancer.
Al-Sukhun S; Hussain M
Cancer; 2003 Apr; 97(8 Suppl):2064-75. PubMed ID: 12673698
[TBL] [Abstract][Full Text] [Related]
10. P53 accumulation in precursor lesions and early stages of bladder cancer.
Schmitz-Dräger BJ; van Roeyen CR; Grimm MO; Gerharz CD; Decken K; Schulz WA; Bültel H; Makri D; Ebert T; Ackermann R
World J Urol; 1994; 12(2):79-83. PubMed ID: 8087143
[TBL] [Abstract][Full Text] [Related]
11. Overcoming cellular senescence in human cancer pathogenesis.
Yeager TR; DeVries S; Jarrard DF; Kao C; Nakada SY; Moon TD; Bruskewitz R; Stadler WM; Meisner LF; Gilchrist KW; Newton MA; Waldman FM; Reznikoff CA
Genes Dev; 1998 Jan; 12(2):163-74. PubMed ID: 9436977
[TBL] [Abstract][Full Text] [Related]
12. Genetic and molecular markers of urothelial premalignancy and malignancy.
Cordon-Cardo C; Cote RJ; Sauter G
Scand J Urol Nephrol Suppl; 2000; (205):82-93. PubMed ID: 11144907
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
[TBL] [Abstract][Full Text] [Related]
14. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.
Grippo PJ; Sandgren EP
Am J Pathol; 2000 Sep; 157(3):805-13. PubMed ID: 10980120
[TBL] [Abstract][Full Text] [Related]
15. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair.
Blanes A; Rubio J; Sanchez-Carrillo JJ; Diaz-Cano SJ
Hum Pathol; 2009 Jul; 40(7):988-97. PubMed ID: 19368958
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
18. Two molecular pathways to transitional cell carcinoma of the bladder.
Spruck CH; Ohneseit PF; Gonzalez-Zulueta M; Esrig D; Miyao N; Tsai YC; Lerner SP; Schmütte C; Yang AS; Cote R
Cancer Res; 1994 Feb; 54(3):784-8. PubMed ID: 8306342
[TBL] [Abstract][Full Text] [Related]
19. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.
Friedrich MG; Blind C; Milde-Langosch K; Erbersdobler A; Conrad S; Löning T; Hammerer P; Huland H
Eur Urol; 2001 Nov; 40(5):518-24. PubMed ID: 11752859
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.
Izawa JI; Slaton JW; Kedar D; Karashima T; Perrotte P; Czerniak B; Grossman HB; Dinney CP
Oncol Rep; 2001; 8(1):9-15. PubMed ID: 11115562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
